Magnetic resonance imaging of major histocompatibility class II expression in the renal medulla using immunotargeted superparamagnetic iron oxide nanoparticles

ACS Nano

Volumn 2, Issue 3, 2008, Pages 477-484

  Hultman, Kristi L ^a   Raffo, Anthony J ^b   Grzenda, Adrienne L ^b   Harris, Paul E ^b   Brown, Truman R ^c   O'Brien, Stephen ^a  

^a Columbia University ^*  (United States)

^b NewYork Presbyterian Hospital   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Contrast agents; Drug delivery; Immunotargeted; Iron oxide nanoparticles; Magnetic resonance imaging; MHC class II; Phospholipid

Indexed keywords

ATOMS; CHEMOTHERAPY; CLADDING (COATING); COMPUTER NETWORKS; DRUG DELIVERY; DRUG DOSAGE; DRUG THERAPY; HEALTH; IMAGING TECHNIQUES; IRON; IRON COMPOUNDS; IRON OXIDES; MAGNETIC FIELDS; MAGNETIC RESONANCE; MAGNETIC RESONANCE IMAGING; MAGNETISM; NANOPARTICLES; NANOSTRUCTURES; PARAMAGNETISM; PHOSPHOLIPIDS; RESONANCE; SUPERPARAMAGNETISM; TARGETS;

AMERICAN CHEMICAL SOCIETY (ACS); COATED NANOPARTICLES; CONJUGATION CHEMISTRY; CONTRAST AGENT (CA); DISEASE DETECTION; FUNCTIONALIZED; IN-VIVO; MAGNETIC (CE); MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) CLASS; MONO DISPERSED; NANO PARTICLES; OXIDE NANO-PARTICLE; PHOSPHOLIPID COATING; POTENTIAL DRUGS; RENAL MEDULLA; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLES (SPION);

NANOSTRUCTURED MATERIALS;

CONTRAST MEDIUM; DIAGNOSTIC AGENT; FERRIC ION; FERRIC OXIDE; HLA ANTIGEN CLASS 2; NANOPARTICLE;

ANIMAL; ARTICLE; CHEMISTRY; DRUG DELIVERY SYSTEM; GENE EXPRESSION PROFILING; HISTOLOGY; IMAGE ENHANCEMENT; IMMUNOHISTOCHEMISTRY; KIDNEY MEDULLA; MAGNETISM; METABOLISM; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; RAT;

ANIMALS; CONTRAST MEDIA; DRUG DELIVERY SYSTEMS; FERRIC COMPOUNDS; GENE EXPRESSION PROFILING; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMAGE ENHANCEMENT; IMMUNOHISTOCHEMISTRY; KIDNEY MEDULLA; MAGNETIC RESONANCE IMAGING; MAGNETICS; NANOPARTICLES; RATS;

EID: 45149113404     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn700400h     Document Type: Article

References (49)

1. Bulte, J. W.; Douglas, T.; Mann, S.; Frankel, R. B.; Moskowitz, B. M.; Brooks, R. A.; Baumgarner, C. D.; Vymazal, J.; Strub, M. P.; Frank J. A. Magnetoferritin: Characterization of a Novel Superparamagnetic MR Contrast Agent. J. Magn. Reson. Imaging 1994, 4, 497-505.
2. Weissleder, R.; Cheng, H. C.; Bogdanova, A.; Bogdanov, A. Magnetically Labeled Cells Can Be Detected by MR Imaging. J. Magn. Reson. Imaging 1997, 7, 258-263.
3. Weissleder, R.; Elizondo, G.; Wittenberg, J.; Rabito, C. A.; Bengele, H. H.; Josephson, L. Ultrasmall Superparamagnetic Iron Oxide: Characterization of a New Class of Contrast Agents for MR Imaging. Radiology 1990, 175, 489-493.
4. Yeh, T. C.; Zhang, W.; Ildstad, S. T.; Ho, C. Intracellular Labeling of T-Cells with Superparamagnetic Contrast Agents. Magn. Reson. Med. 1993, 30, 617-625.
5. Denizot, B.; Tanguy, G.; Hindre, F.; Rump, E.; Jacques Le Jeune, J.; Jallet, P. Phosphorylcholine Coating of Iron Oxide Nanoparticles. J. Colloid Interface Sci. 1999, 209, 66-71.
6. Zhang, Y.; Dodd, S. J.; Hendrich, K. S.; Williams, M.; Ho, C. Magnetic Resonance Imaging Detection of Rat Renal Transplant Rejection by Monitoring Macrophage Infiltration. Kidney Int. 2000, 58, 1300-1310.
7. Drummond, D. C.; Meyer, O.; Hong, K.; Kirpotin, D. B.; Papahadjopoulos, D. Optimizing Liposomes for Delivery of Chemotherapeutic Agents to Solid Tumors. Pharmacol. Rev. 1999, 51, 691-743.
8. Lee, J. H.; Huh, Y. M.; Jun, Y. W.; Seo, J. W.; Jang, J. T.; Song, H. T.; Kim, S.; Cho, E. J.; Yoon, H. G.; Suh, J. S. Artificially Engineered Magnetic Nanoparticles for Ultra-Sensitive Molecular Imaging. Nature Med. 2007, 13, 95-99.
9. Hultman, K.; Willis, A.; O'Brien, S.; Brown, T. R.; Harris, P.; Turro, N. J.; Grzenda, A. L Synthesis and Conjugation of Iron Oxide Nanoparticles to Antibodies for Targeting Specific Cells Using Fluorescence and MR Imaging Techniques. U.S. Patent Appl. 20070059775, March 29, 2006.
10. Weissleder, R.; Elizondo, G.; Wittenberg, J.; Lee, A. S.; Josephson, L.; Brady, T. J. Ultrasmall Superparamagnetic Iron Oxide: An Intravenous Contrast Agent for Assessing Lymph Nodes with MR Imaging. Radiology 1990, 175, 494-498.
11. Isobe, M.; Narula, J.; Southern, J. F.; Strauss, H. W.; Khaw, B. A.; Haber, E. Imaging the Rejecting Heart. In Vivo Detection of Major Histocompatibility Complex Class II Antigen Induction. Circulation 1992, 85, 738-746.
12. Wu, Y. L; Ye, Q.; Foley, L. M.; Hitchens, T. K.; Sato, K; Williams, J. B.; Ho, C. In Situ Labeling of Immune Cells with Iron Oxide Particles: An Approach to Detect Organ Rejection by Cellular MRI. Proc. Natl. Acad. Sci. 2006, 103, 1852-1857.
13. Corot, C.; Robert, P.; Idee, J. M.; Port, M. Recent Advances in Iron Oxide Nanocrystal Technology for Medical Imaging. Adv. Drug Delivery Rev. 2006, 58, 1471-1504.
14. Jendelova, P.; Herynek, V.; Urdzikova, L.; Glogarova, K.; Kroupova, J.; Andersson, B.; Bryja, V.; Burian, M.; Hajek, M.; Sykova, E. Magnetic Resonance Tracking of Transplanted Bone Marrow and Embryonic Stem Cells Labeled by Iron Oxide Nanoparticles in Rat Brain and Spinal Cord. J. Neurosci. Res. 2004, 76, 232-243.
15. Jain, T. K.; Morales, M. A.; Sahoo, S. K.; Leslie-Pelecky, D. L.; Labhasetwar, V. Iron Oxide Nanoparticles for Sustained Delivery of Anticancer Agents. Mol. Phormaceutics 2005, 2, 194-205.
16. Ito, A.; Kuga, Y.; Honda, H.; Kikkawa, H.; Horiuchi, A.; Watanabe, Y.; Kobayashi, T. Magnetite Nanoparticle-Loaded Anti-Her2 Immunoliposomes for Combination of Antibody Therapy with Hyperthermia. Cancer Lett. 2004, 212, 167-175.
17. Simberg, D.; Duza, T.; Park, J. H.; Essler, M., Pilch, J.; Zhang, L.; Derfus, A. M.; Yang, M.; Hoffman, R. M.; Bhatia, S. Blornimetic Amplification of Nanoparticle Homing to Tumors. Proc. Natl. Acad. Sci. 2007, 104, 932-936.
18. Stark D. D.; Weissleder, R.; Elizondo, G.; Hahn, P. F.; Saini, S.; Todd, L. E.; Wittenberg, J.; Ferrucci, J. T. Superparamagnetic Iron Oxide: Clinical Application as a Contrast Agent for MR Imaging of the Liver. Radiology 1988, 168, 297-301.
19. Hyeon, T.; Lee, S. S.; Park J.; Chung, Y.; Na, H. B. Synthesis of Highly Crystalline and Monodisperse Maghemite Nanocrystallites without a Size-Selection Process. J. Am. Chem. Soc. 2001, 123, 12798-12801.
20. Grancharov, S.; Zeng, H.; Sun, S.; Wang, S. X.; O'Brien, S. P.; Murray, C. B.; Kirtley, J. R.; Held, G. A. Bio-Functionalization of Monodisperse Magnetic Nanoparticles and Their Use as Biomolecular Labels in a Magnetic Tunnel Junction Based Sensor. J. Phys. Chem. B 2005, 109, 13030-13035.
21. Willis, A. L; Turro, N. J.; O'Brien, S. Spectroscopic Characterization of the Surface of Iron Oxide Nanocrystals. Chem. Mater. 2005, 17, 5970-5975.
22. Goldenberg, D. M.; Sharkey, R. M.; Paganelli, G.; Barbet, J.; Chatal, J. F. Antibody Pretargeting Advances Cancer Radioimmunodetection and Radioimmunotherapy. J. Clin. Oncol. 2006, 24, 823-834.
23. Renshaw, P. F.; Owen, C. S.; McLaughlin, A. C.; Frey, T. G.; Leigh, J. S. Ferromagnetic Contrast Agents: A New Approach. Magn. Reson. Med. 1986, 3, 217-225.
24. Reimer, P.; Jahnke, N.; Fiebich, M.; Schima, W.; Deckers, F.; Marx, C.; Holzknecht, N.; Saini, S. Hepatic Lesion Detection and Characterization: Value of Nonenhanced MR Imaging, Superparamagnetic Iron Oxide-Enhanced MR Imaging, and Spiral Ct-Roc Analysis. Radiology 2000, 217, 152-158.
25. Zhao, M.; Kircher, M. F.; Josephson, L.; Weissleder, R. Differential Conjugation of Tat Peptide to Superparamagnetic Nanoparticles and Its Effect on Cellular Uptake. Bioconjugate Chem. 2002, 13, 840-844.
26. Thunemann, A. F.; Schutt, D.; Kaufner, L.; Pison, U., Mohwald, H. Maghemite Nanoparticles Protectively Coated with poly(ethylene imine) and poly(ethylene oxide)- block-poly(glutamic acid). Langmuir 2006, 22, 2351-2357.
27. Veiga, V.; Ryan, D. H.; Sourty, E.; Llanes, F. Machessault Formation and Characterization of Superparamagnetic Crosslinked High-Amylose Starch. Carbohydr. Polym. 2000, 42, 353-357.
28. Dubertret, B.; Skourides, P.; Norris, D. J.; Noireaux, V.; Brivaniou, A. H.; Libchaber, A. In Vivo Imaging of Quantum Dots Encapsulated in Phospholipid Micelles. Science 2002, 298, 1759-1762.
29. Senior, J.; Delgado, C.; Fisher, D.; Tilcock C.; Gregorladis, G. Influence of Surface Hydrophilicity of Liposomes on Their Interaction with Plasma Protein and Clearance from the Circulation: Studies with Poly(Ethylene Glycol)-Coated Vesicles. Biochim. Biophys. Acta 1991, 1062, 77-82.
30. Klibanov, A. L.; Maruyama, K.; Torchilin, V. P.; Huang, L. Amphipathic Polyethyleneglycols Effectively Prolong the Circulation Time of Liposomes. FEBS Lett. 1990, 268, 235-237.
31. Veiseh, O.; Sun, C.; Gunn, J.; Kohler, N.; Gabikian, P., Lee, D.; Bhattarai, N., Ellenbogen, R.; Sze, R.; Hallahan, A. Optical and MRI Multifunctional Nanoprobe for Targeting Gliomas. Nano Lett. 2005, 5, 1003-1008.
32. Williams, D. N.; Ehrman, S. H.; Holoman, T. R. P. Evaluation of the Microbial Growth Response to Inorganic Nanoparticles. J. Nanobiotechnol. 2006, 4, 3.
33. Moghimi, S. M.; Hunter, A. C.; Murray, J. C. Long-Circulating and Target-Specific Nanoparticles: Theory to Practice. Pharmacol. Rev. 2001, 53, 283-318.
34. Moghimi, S. M.; Szebeni, J. Stealth Liposomes and Long Circulating Nanoparticles: Critical Issues in Pharmacokinetics, Opsonization and Protein-Binding Properties. Prog. Lipid Res. 2003, 42, 463-478.
35. Allen, T. M.; Hansen, C.; Martin, F.; Redemann, C.; Yau-Young, A. Liposomes Containing Synthetic Lipid Derivatives of Poly(Ethylene Glycol) Show Prolonged Circulation Half-Lives in Vivo. Biochim. Biophys. Acta 1991, 1066, 29-36.
36. Moghimi, S. M. The Effect of Methoxy-Peg Chain Length and Molecular Architecture on Lymph Node Targeting of Immuno-PEG Liposomes. Blomaterials 2006, 27, 136-144.
37. Na, H. B.; Lee, J. H.; An, K.; Park, Y. I.; Park, M.; Lee, I. S.; Nam, D. H.; Kim, S. T.; Kim, S. H.; Kim, S. W. Development of a T1 Contrast Agent for Magnetic Resonance Imaging Using MNO Nanoparticles. Angew. Chem, Int. Ed. 2007, 46, 5397-5401.
38. Idiyatullin, D.; Corum, C.; Park J. Y.; Garwood, M. Fast and Quiet MRI Using a Swept Radiofrequency. J. Magn. Reson. 2006, 181, 342-349.
39. Simon, G. H.; Bauer, J.; Saborovski, O.; Fu, Y.; Corot, C.; Wendland, M. F.; Daldrup-Link H. E. T1 and T2 Relaxivity of Intracellular and Extracellular Uspio at 1.5t and 3t Clinical MR Scanning. Eur. Radiol. 2006, 16, 738-745.
40. Paul, L. C.; Paradysz, J. M., Milford, E. L.; Kunz, H. W.; Carpenter, C. B. Expression of Rt1.A and Rt1.B/D Antigens on Endothelium of Rat Kidneys. Transplantation 1982, 34, 121-128.
41. Roos, A.; Schilder-Tol, E. J.; Chand, M. A.; Weening, J. J.; Aten, J. Hgcl2 and II4 Differentially Modify Expression of Major Histocompatibility Complex Class II Molecules Rt1.B and Rt1.D in B Lymphocytes from Brown Norway and Lewis Rats. Transplantation Proc. 1997, 29, 1675-1676.
42. Beckmann, N.; FalK R.; Zurbrugg, S.; Dawson, J.; Engelhardt, P. Macrophage Infiltration into the Rat Knee Detected by MRI in a Model of Antigen-induced Arthritis. Magn. Reson. Med. 2003, 49, 1047-1055.
43. Trivedi, R. A.; Mallawarachi, C.; JM, U. K.-I.; Graves, M. J.; Horsley, J.; Goddard, M. J.; Brown, A.; Wang, L, Kirkpatrick, P. J.; Brown, J.; et al. Identifying Inflamed Carotid Plaques Using in Vivo Uspio-Enhanced Mr Imaging to Label Plaque Macrophages. Arterioscler. Thromb. Vasc. Biol 2006, 26, 1601-1606.
44. Muczynski, K. A.; Elde, D. M.; Coder, D. M.; Anderson, S. K. Normal Human Kidney Hla-Dr-Expressing Renal Microvascular Endothelial Cells: Characterization, Isolation, and Regulation of MHC Class II Expression. J. Am. Soc. Nephrol. 2003, 14, 1336-1348.
45. Metzger, R.; Mempel, T.; Joppich, I.; Till, H. Organ-Specific Distribution of Major Histocompatibility Antigens in Rats. Pediatr. Surg. Int. 2000, 16, 285-292.
46. Lavoie, P. M.; McGrath, H.; Shoukry, N. H.; Cazenave, P. A.; Sekaly, R. P.; Thibodeau, J. Quantitative Relationship between MHC Class II-Superantigen Complexes and the Balance of T Cell Activation Versus Death. J. Immunol. 2001, 166, 7229-7237.
47. Harding, C. V.; Unanue, E. R. Antigen Processing and Intracellular ia. Possible Roles of Endocytosis and Protein Synthesis in la Function. J. Immunol. 1989, 142, 12-19.
48. Bishop, G. A.; Waugh, J. A.; Hall, B. M. Expression of Hla Antigens on Renal Tubular Cells in Culture: II. Effect of Increased Hla Antigen Expression on Tubular Cell Stimulation of Lymphocyte Activation and on Their Vulnerability to Cell-Mediated Lysis. Transplantation 1988, 46, 303-310.
49. Nietosvaara, Y.; Renkonen, R.; Mattila, P.; Hyry, P. Cultured Rat Kidney Parenchymal Components Are Damaged by Cytotoxic Lymphocytes Produced in Mlc. APMIS 1990, 98, 724-728.